ONE STEP Multi-3 DOA Test

Dénomination commerciale

ONE STEP Multi-3 DOA Test

06936155807024

B-06936155807024

Numéro de référence/catalogue

ITP06102-DT20

GS1

IVDD — Général

Législation applicable

IVDD [Directive 98/79/CE relative aux dispositifs médicaux de diagnostic in vitro]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

The One Step Multi-3 DOA Test is a rapid, qualitative, competitive immunoassay for the determination of Drug-of-Abuse (DOA) and/or their metabolites in human urine. The device allows the detection of multiple drugs in one simple step. The One Step Multi-3 DOA Test is intended to be used in Professional Medical & Forensic laboratories. This test provides only preliminary data which should be confirmed by other methods such as gas chromatography / mass spectrophotometry (GC/MS). This test is not intended to monitor drug levels, but only to screen urine for the presence of the drugs mentioned and their metabolites. The test is used for screening common drugs of abuse and/or their metabolites in urine, including analytes such as amphetamines, cocaine/benzoylecgonine, opiates/morphine, THC/cannabinoids, methamphetamine, benzodiazepines, barbiturates, phencyclidine, MDMA, ketamine, TCA, methadone, buprenorphine and tramadol, depending on the test configuration. The One Step Multi-3 DOA Test is based on a competitive immunoassay principle and consists of 3 chromatographic strip(s), as per the format, for individual drugs of abuse. Urine initially reacts with antibody-colloidal gold conjugate and migrates by capillary action to the test area. If sufficient drug is present, it prevents the conjugate from binding to the drug conjugate immobilized on the membrane in the test region, so a positive specimen produces only the control line. A negative specimen produces both test and control lines. The control line indicates that the result is valid.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• W0102160511MULTIPLE DRUGS OF ABUSE/TOXICOLOGY RT & POC

4 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW032

  Do not use the kit beyond the expiration date imprinted on the outside of the foil pouch.
• CW011

  For professional Medical and Forensic use only and for in vitro diagnostic use only. This test provides preliminary screening results only and is not intended to monitor drug levels or determine quantitative drug levels. Positive results should be confirmed by GC/MS or another appropriate method. Avoid cross-contamination by using a new urine sample cup for each sample and do not interpret results after 8 minutes.
• CW010

  Read and follow the package insert carefully before use.
• CW008

  Properly handle and dispose of residual urine and all used reaction devices in an approved biohazard container.